Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Interest Expenses (2016 - 2025)

vTv Therapeutics' Interest Expenses history spans 11 years, with the latest figure at $1000.0 for Q4 2025.

  • For Q4 2025, Interest Expenses changed N/A year-over-year to $1000.0; the TTM value through Dec 2025 reached $1000.0, changed N/A, while the annual FY2025 figure was $6000.0, N/A changed from the prior year.
  • Interest Expenses for Q4 2025 was $1000.0 at vTv Therapeutics, down from $7000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $8000.0 in Q3 2022 and bottomed at $1000.0 in Q1 2022.
  • The 4-year median for Interest Expenses is $6000.0 (2021), against an average of $4555.6.
  • The largest annual shift saw Interest Expenses tumbled 97.45% in 2021 before it surged 33.33% in 2022.
  • A 4-year view of Interest Expenses shows it stood at $6000.0 in 2021, then changed by 0.0% to $6000.0 in 2022, then increased by 16.67% to $7000.0 in 2023, then crashed by 85.71% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Interest Expenses are $1000.0 (Q4 2025), $7000.0 (Q4 2023), and $4000.0 (Q3 2023).